SCHEMBL4771601

SCHEMBL4771601

COc1ccc(OC)c(CCC(=O)Nc2sc3c(c2C#N)CCN(C(=O)CCc2cnccc2OC)C3)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
KDM4E B2RXH2 1/20 0.49
STAT3 P40763 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
GRM5 P41594 3/20 0.45
P2RX3 P56373 1/20 0.45
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
GRM1 Q13255 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
TGFBR1 P36897 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2964118 0.93 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2970407 0.93 MEN1 (0.52) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2959937 0.92 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2955030 0.90 ALDH1A1 (0.53) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2963198 0.89 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2955287 0.89 MEN1 (0.55) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2968913 0.89 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2969066 0.88 MEN1 (0.53) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2970492 0.88 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2958032 0.88 ALDH1A1 (0.47) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed